This paper is in the following e-collection/theme issue:

Non-Randomized Studies (funded, non-eHealth) (145) Cost-Effectiveness and Economics (252) Health Services Research (487) E-Health / Health Services Research and New Models of Care (529) Cancer Survivorship (259) Health Services Research in Oncology (35) Innovations and Technology in Cancer Care (427) Nutrition, Physical Activity, Healthy Lifestyle for Cancer Patients and Survivors (138)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/55601, first published .
Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design

Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design

Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design

Authors of this article:

Eline M J Lammers1 Author Orcid Image ;   Josée M Zijlstra2 Author Orcid Image ;   Valesca P Retèl3 Author Orcid Image ;   Berthe M P Aleman4 Author Orcid Image ;   Flora E van Leeuwen1 Author Orcid Image ;   Annelies Nijdam1 Author Orcid Image ;   BETER consortium5
Article Authors Cited by Tweetations (5) Metrics

Eline M J Lammers   1 , MD ;   Josée M Zijlstra   2 , MD, PhD ;   Valesca P Retèl   3 , PhD ;   Berthe M P Aleman   4 , MD, PhD ;   Flora E van Leeuwen   1 , PhD ;   Annelies Nijdam   1 , PhD ;   BETER consortium   5

1 Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands

2 Department of Hematology, Amsterdam UMC, location Vrije Universiteit, Cancer Center, Amsterdam, Netherlands

3 Department of Health Technology Assessment, The Netherlands Cancer Institute, Amsterdam, Netherlands

4 Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands

5 See Acknowledgements, Amsterdam, Netherlands

Corresponding Author:

  • Annelies Nijdam, PhD
  • Department of Epidemiology
  • The Netherlands Cancer Institute
  • Plesmanlaan 121
  • Amsterdam, 1066 CX Amsterdam
  • Netherlands
  • Phone: 31 20-5126132
  • Email: a.nijdam@nki.nl